KRYS
KRYS
US5011471027
Krystal Biotech, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
9.82B EUR
11B EUR
7.6B EUR
7.2B EUR
Enterprise Value
8.85B EUR
10.58B EUR
7.11B EUR
6.71B EUR
Valuation Multiples
Trailing P/E
41.56x
45.56x
33.79x
42.56x
Forward P/E
35.78x
--
--
--
Price to Sales
22.28x
24.97x
18.22x
23.91x
Price to Book
7.22x
8.09x
5.96x
5.9x
EV/Revenue
20.09x
24.02x
17.04x
22.3x
EV/EBITDA
44.41x
51.76x
38.37x
51.63x
Price to FCF (P/FCF)
64.68x
42.67x
32.03x
43.84x
EV/FCF
58.33x
41.05x
29.96x
40.88x
FCF Yield
1.55%
2.34%
3.12%
2.28%
ende